Literature DB >> 22181010

A neuroprotective role for the DNA damage checkpoint in tauopathy.

Vikram Khurana1, Paola Merlo, Brian DuBoff, Tudor A Fulga, Katherine A Sharp, Shelagh D Campbell, Jürgen Götz, Mel B Feany.   

Abstract

ATM and p53, effectors of the DNA damage checkpoint, are generally considered pro-apoptotic in neurons. We show that DNA damage and checkpoint activation occurs in postmitotic neurons in animal models of tauopathy, neurodegenerative disorders that include Alzheimer's disease. Surprisingly, checkpoint attenuation potently increases neurodegeneration through aberrant cell cycle re-entry of postmitotic neurons. These data suggest an unexpected neuroprotective role for the DNA damage checkpoint in tauopathies.
© 2011 The Authors. Aging Cell © 2011 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland.

Entities:  

Mesh:

Year:  2012        PMID: 22181010     DOI: 10.1111/j.1474-9726.2011.00778.x

Source DB:  PubMed          Journal:  Aging Cell        ISSN: 1474-9718            Impact factor:   9.304


  25 in total

1.  Lamin Dysfunction Mediates Neurodegeneration in Tauopathies.

Authors:  Bess Frost; Farah H Bardai; Mel B Feany
Journal:  Curr Biol       Date:  2015-12-24       Impact factor: 10.834

2.  p53 prevents neurodegeneration by regulating synaptic genes.

Authors:  Paola Merlo; Bess Frost; Shouyong Peng; Yawei J Yang; Peter J Park; Mel Feany
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-01       Impact factor: 11.205

3.  Tau promotes neurodegeneration via DRP1 mislocalization in vivo.

Authors:  Brian DuBoff; Jürgen Götz; Mel B Feany
Journal:  Neuron       Date:  2012-08-23       Impact factor: 17.173

4.  PIWIL1 protein power targets tau therapy.

Authors:  Sandra-Fausia Soukup; Patrik Verstreken
Journal:  Nat Neurosci       Date:  2014-03       Impact factor: 24.884

Review 5.  The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD.

Authors:  Sally Hunter; Thomas Arendt; Carol Brayne
Journal:  Mol Neurobiol       Date:  2013-04-03       Impact factor: 5.590

6.  Biotin rescues mitochondrial dysfunction and neurotoxicity in a tauopathy model.

Authors:  Kelly M Lohr; Bess Frost; Clemens Scherzer; Mel B Feany
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-14       Impact factor: 11.205

Review 7.  Modeling the complex pathology of Alzheimer's disease in Drosophila.

Authors:  Pedro Fernandez-Funez; Lorena de Mena; Diego E Rincon-Limas
Journal:  Exp Neurol       Date:  2015-05-27       Impact factor: 5.330

Review 8.  Connecting the dots between tau dysfunction and neurodegeneration.

Authors:  Bess Frost; Jürgen Götz; Mel B Feany
Journal:  Trends Cell Biol       Date:  2014-08-26       Impact factor: 20.808

9.  Tau Mutations Serve as a Novel Risk Factor for Cancer.

Authors:  Giacomina Rossi; Veronica Redaelli; Paolo Contiero; Sabrina Fabiano; Giovanna Tagliabue; Paola Perego; Luisa Benussi; Amalia C Bruni; Graziella Filippini; Mariangela Farinotti; Giorgio Giaccone; Simona Buiatiotis; Claudia Manzoni; Raffaele Ferrari; Fabrizio Tagliavini
Journal:  Cancer Res       Date:  2018-05-24       Impact factor: 12.701

10.  Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment.

Authors:  Stefano Martellucci; Letizia Clementi; Samantha Sabetta; Paola Muzi; Vincenzo Mattei; Mauro Bologna; Adriano Angelucci
Journal:  J Cancer Res Clin Oncol       Date:  2021-04-02       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.